Cited by 42Congenital Heart Disease StudiesTissue Engineering and Regenerative MedicineAortic Disease and Treatment Approaches

Initial 2-year results of CardioCel® patch implantation in children

Pavy, Carine, Michielon, Guido, Robertus, Jan Lukas, Lacour-Gayet, François, Ghez, Olivier·2018·Interactive CardioVascular and Thoracic Surgery

Abstract

OBJECTIVES: We present the initial 2-year results of CardioCel® patch (Admedus Regen Pty Ltd, Perth, WA, Australia) implantation in paediatric patients with congenital heart diseases. METHODS: This was a single-centre retrospective study with prospectively collected data of all patients aged 18 years and under operated for congenital heart disease. The patch was introduced in 2014, with clinical practice committee approval and a special consent in case of an Ozaki procedure. Standard follow-up was performed with systematic clinical exams and echocardiograms. In case of reoperation or graft failure, the patch was removed and sent for a histological examination. RESULTS: Between March 2014 and April 2016, 101 patients had surgical repair using a CardioCel patch. The mean age was 22 (±36.3) months, and the mean weight was 9.7 (±10.3) kg. No infections and no intraoperative implantation difficulties were associated with the patch. The median follow-up period was 212 (range 4-726) days. The overall 30-day postoperative mortality was 3.8% (n = 4), none of which were related to graft failure. Five children were reoperated because of graft failure, 4 of whom had the patch implanted for aortic and were aged less than 10 days. The indications for patch implantation in the aortic position were aortopulmonary window, truncus arteriosus, coarctation and aortic arch hypoplasia repair. The median time between the first and the second operation for graft failure was 245 (range 5-480) days. CONCLUSIONS: Our experience shows that the patch is well tolerated in the septal, valvar and pulmonary artery positions. However, we experienced graft failures in infants in the aortic position.

Integrity signals

Registry

Crossref · 10.1093/icvts/ivx295

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ECM bioscaffolds provide an alternative to congenital infant defects such as those related to heart valves, given their prominent integration with the host's tissue and prevention of inflammation.

    “On the other hand, ECM bioscaffolds provide an alternative to congenital infant defects such as those related to heart valves [209,210], given their prominent integration with the host's tissue and prevention of inflammation.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pavy, C., Michielon, G., Robertus, J. L., Lacour-Gayet, F., & Ghez, O.
Affiliations
  • Royal Brompton Hospital (GB)
  • Department of Cardiac Surgery, Royal Brompton Hospital, London, UK
Corresponding author
Ghez, Olivier
Venue
Interactive CardioVascular and Thoracic Surgery
Published
2017-10-24
Volume
26
Issue
3
Pages
448-453
ISSN
  • 1569-9285 (ISSN-L)
  • 1569-9293
OpenAlex
W2766416039
Cited by
42
References
12
Citations by year
2025: 6 · 2024: 7 · 2023: 5 · 2022: 8 · 2021: 4 · 2020: 1 · 2019: 8 · 2018: 2 · 2017: 1
FWCI
2.58
Type
journal article
Language
en
Open access
closed
Locations
  • Interactive Cardiovascular and Thoracic Surgery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Congenital Heart Disease Studies
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Aortic Disease and Treatment Approaches
Keywords
congenital heart disease, pediatric cardiac surgery, graft failure, aortopulmonary window, truncus arteriosus, coarctation of the aorta, aortic arch hypoplasia, reoperation, long-term outcomes
MeSH terms
Adolescent, Bioprosthesis, Blood Vessel Prosthesis, Child, Child, Preschool, Female, Heart Defects, Congenital, Humans, Infant, Infant, Newborn, Male, Reoperation, Retrospective Studies, Time Factors, Treatment Outcome, Blood Vessel Prosthesis Implantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review